Related Experiment Video
Updated: Apr 5, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
Published on: February 1, 2019
Biomaterials for mRNA delivery
Mohammad Ariful Islam1, Emma K G Reesor, Yingjie Xu
1Laboratory for Nanoengineering & Drug Delivery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. jinjun.shi@zeus.bwh.harvard.edu.
Abstract:
Messenger RNA (mRNA) has recently emerged with remarkable potential as an effective alternative to DNA-based therapies because of several unique advantages. mRNA does not require nuclear entry for transfection activity and has a negligible chance of integrating into the host genome which excludes the possibility of potentially detrimental genomic alternations. Chemical modification of mRNA has further enhanced its stability and decreased its activation of innate immune responses. Additionally, mRNA has been found to have rapid expression and predictable kinetics. Nevertheless, the ubiquitous application of mRNA remains challenging given its unfavorable attributes, such as large size, negative charge and susceptibility to enzymatic degradation. Further refinement of mRNA delivery modalities is therefore essential for its development as a therapeutic tool. This review provides an exclusive overview of current state-of-the-art biomaterials and nanotechnology platforms for mRNA delivery, and discusses future prospects to bring these exciting technologies into clinical practice.
Insights
Messenger RNA (mRNA) offers advantages over DNA therapies but faces delivery challenges. Advanced biomaterials and nanotechnology are crucial for overcoming these hurdles and enabling mRNA therapeutics.
Area of Science:
- Biotechnology
- Nanomedicine
- Molecular Biology
Background:
- Messenger RNA (mRNA) presents a promising alternative to DNA-based therapies due to its unique advantages.
- mRNA therapies avoid nuclear entry and genomic integration, mitigating risks of harmful genetic alterations.
- Chemical modifications enhance mRNA stability and reduce innate immune responses, while rapid expression and predictable kinetics are beneficial.
Purpose of the Study:
- To provide an overview of current biomaterials and nanotechnology for mRNA delivery.
- To discuss the challenges and future prospects of mRNA therapeutic development.
Main Methods:
- Review of state-of-the-art biomaterials for mRNA delivery.
- Analysis of nanotechnology platforms enabling mRNA transfection.
- Discussion of mRNA characteristics impacting therapeutic applications.
Main Results:
- mRNA offers advantages like no nuclear entry and no genomic integration.
- Chemical modifications improve mRNA stability and reduce immunogenicity.
- Challenges include mRNA's size, charge, and susceptibility to degradation.
Conclusions:
- Refined mRNA delivery systems are essential for therapeutic development.
- Biomaterials and nanotechnology are key to overcoming current mRNA limitations.
- Future prospects involve translating these advanced delivery technologies into clinical practice.
Related Concept Videos
Regulated mRNA Transport
Regulated mRNA Transport
mRNA Stability and Gene Expression
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Nucleic Acid Structure
DNA Structure
DNA...
Nuclear Export of mRNA

